Frequently Asked Questions

At year-end 2023, Bavarian Nordic had 1,379 full-time employees.

Bavarian Nordic has subsidiaries in USA, Germany and Switzerland. See more under Locations.

Bavarian Nordic is a leading global supplier of travel vaccines, with a commercial portfolio encompassing the following products:

• Rabipur®/RabAvert® - rabies vaccine
• Encepur® - tick-borne encephalitis vaccine
• Vivotif® - typhoid vaccine
• Vaxchora® - cholera vaccine

The travel vaccine portfolio further includes Ixiaro® (Japanese encephalitis) vaccine, Dukoral® (cholera vaccine) and HEPLISAV-B® (hepatitis A vaccine), all products that have been inlicensed from other companies and which are marketed and distributed by Bavarian Nordic in select markets.

We are furthermore a preferred partner to governments on vaccines for public preparedness, being a supplier to more than 70 countries of our smallpox/mpox vaccine:

• JYNNEOS®/IMVANEX®/IMVAMUNE® - smallpox/mpox vaccine

Bavarian Nordic's auditors are KPMG.

Bavarian Nordic's lawyers are Kromann Reumert.

Bavarian Nordic shares are traded on Nasdaq Copenhagen under the ticker symbol BAVA.

An ADR program has been established allowing U.S. investors to trade the stock locally on the OTC market under the ticker symbol BVNRY.

Bavarian Nordic's IPO was in 1998.

Bavarian Nordic has approximately 116,000 registered shareholders (September 2024).

Bavarian Nordic has 78,832,982 outstanding shares.

No.

Yes, for more information see the ADR Program page.

No, but Bavarian Nordic stock can be purchased through just about any brokerage firm, including online brokerage services.

Bavarian Nordic has never declared dividends. 

In the short term, Bavarian Nordic’s main priority to use the cash generated to pay the significant milestones to GSK and Emergent BioSolutions which are
due in 2024 and 2025. In the mid-to long term, the Company expects to increase its financial flexibility through a strong positive cash flow and increased access to debt financing, which it intends to use to invest in growing the existing business, including the pipeline and selective acquisitions as well as return excess cash to its shareholders.

The Company’s register of shareholders is kept by Computershare A/S, who also maintains our shareholder portal.  If you are a registered shareholder, you can access the shareholder portal and view your holding of shares and register your e-mail address to receive certain electronic investor information. You can also request admission card and/or vote for the annual general meeting.

Computershare A/S
Lottenborgvej 26 D, 1.
DK-2800 Kgs. Lyngby
Denmark

Phone: +45 4546 0999
E-mail: info@computershare.dk

If you own shares through a bank or brokerage firm, you need to contact the bank or brokerage firm directly to change your account address.

The 2023 annual general meeting was held on April 16, 2024. See Events & Presentations for more details.

The next ordinary general meeting will be held on April 9, 2025

See this page for further information.

Bavarian Nordic's fiscal year runs from January 1 to December 31.

Our annual report is published electronically as a PDF file only.

Yes, we publish quarterly reports. See Financial Reports for details.

At Bavarian Nordic we are committed to being socially and environmentally responsible and to comply with all relevant laws, standards and guidelines. We maintain a strong corporate governance structure and communicate openly and transparently about our efforts.

More information can be found on the Corporate Governance and Sustainability sections of this website.